Picture of Taiko Pharmaceutical logo

4574 — Taiko Pharmaceutical News Story

0.000.00%
jp flag iconLast trade - 00:00
HealthcareAdventurousSmall CapNeutral

Table: Taiko Pharmaceutical -2016/17 parent results

May 12 (Reuters)-  
          Taiko Pharmaceutical Co Ltd  
          PARENT-ONLY FINANCIAL HIGHLIGHTS  
     (in billions of yen unless specified) 
                   Year ended      Year ended       Year to     NEXT      
                Mar 31, 2017    Mar 31, 2016   Mar 31, 2018     YEAR      
                   LATEST         YEAR-AGO        COMPANY      COMPANY    
                   RESULTS         RESULTS       FORECAST    H1 FORECAST  
  Sales             7.82            7.64                                  
                 (+2.4 pct)      (-10.4 pct)                              
  Operating         1.36            1.08                                  
                 (+25.3 pct)     (-53.1 pct)                              
  Recurring         1.22            1.69                                  
                 (-28.2 pct)     (-33.9 pct)                              
  Net              878 mln          1.29                                  
                 (-32.1 pct)     (-22.5 pct)                              
  EPS             63.98 yen      100.49 yen                               
  EPS Diluted     63.44 yen       98.32 yen                               
  Ann Div         20.00 yen       15.00 yen      15.00 yen                
  -Q2 Div            NIL             NIL            NIL                   
  -Q4 Div         20.00 yen       15.00 yen      15.00 yen                
   
  NOTE - Taiko Pharmaceutical Co Ltd.  
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4574.T 
  ((Tokyo Headline News Desk +813 6441 1812))

Recent news on Taiko Pharmaceutical

See all news